Announced Sat, 11 Jul · 17:32 IST
Sandu Pharma MD passes away; Viswanathan takes over as CMD
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.2%1-day move
₹41.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.2+0.0-3.4-1.5—+0.0————
Up moveDown movePending
AI summary
Sandu Pharmaceuticals Managing Director Umesh B. Sandu passed away on June 19, 2026. The board appointed Dr Neeti Madan Kapre as Additional Non-Executive Independent Director for 5 years, and redesignated existing Chairman Balram Viswanathan as Chairman and Managing Director for 3 years effective July 11, 2026. Board committees were reconstituted and the vigil mechanism policy was updated.
Likely market impact
Short-term sentiment may be negative due to loss of promoter MD; succession appears orderly with internal elevation of existing Chairman.